Linking genomics with proteomics to accelerate the search for drug targets

Download the white paper

A summary of three recently published research studies that highlight the importance of linking genetic and protein expression data in the context of disease phenotypes in order to identify new, robust drug targets. While many drugs are developed based on genomic findings, it’s common for these drugs to fail in the clinical phase due to their inability to provide the expected results for successful treatment. This is because most drugs target proteins, not genes. Researchers are finding that a combined approach that integrates genomics with proteomics can overcome these challenges.

Related Articles